Literature DB >> 16223945

Desensitization of the peristaltic reflex induced by mucosal stimulation with the selective 5-HT4 agonist tegaserod.

John R Grider1.   

Abstract

The intestinal peristaltic reflex induced by mucosal stimulation is mediated by mucosal release of serotonin (5-HT), which acts on 5-HT(4) receptors located on CGRP-containing afferent nerve terminals. Exposure of the colonic mucosa to the 5-HT(4) receptor agonist tegaserod in the range of 1 nM to 10 muM elicits a peristaltic reflex and stimulates colonic propulsion. The present study was designed to identify the 5-HT(4) receptor subtype mediating the reflex and determine whether functionally effective concentrations of tegaserod desensitize the reflex induced by mucosal stimulation. Exposure of rat colonic mucosa to tegaserod in the range of 5 nM to 5 muM for 5 or 10 min caused rapid time- and concentration-dependent desensitization of the peristaltic reflex induced by mucosal stroking, consistent with the operation of a rapidly desensitizing 5-HT(4b) receptor subtype. Desensitization was accompanied by a decrease in CGRP release. The rate of recovery of peristaltic response depended on the desensitizing concentration of tegaserod: ascending contraction and descending relaxation recovered within 15 min after 5-50 nM tegaserod, 30 min after 0.5 muM, and 60 min after 5 muM. Neither CGRP release nor the peristaltic reflex induced by muscle stretch was affected by 5-HT(4) receptor desensitization, providing further evidence that 5-HT does not mediate the reflex induced by muscle stretch. These results suggest in cases of increased 5-HT availability or prolonged exposure, such as colitis, that it is likely the peristaltic reflex will be blunted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16223945     DOI: 10.1152/ajpgi.00326.2005

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  9 in total

Review 1.  Serotonin and neuroprotection in functional bowel disorders.

Authors:  M D Gershon; M-T Liu
Journal:  Neurogastroenterol Motil       Date:  2007-08       Impact factor: 3.598

Review 2.  Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets.

Authors:  Gary M Mawe; Jill M Hoffman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-06-25       Impact factor: 46.802

Review 3.  Serotonin and colonic motility.

Authors:  D M Kendig; J R Grider
Journal:  Neurogastroenterol Motil       Date:  2015-07       Impact factor: 3.598

4.  Prokinetic actions of luminally acting 5-HT4 receptor agonists.

Authors:  John R Konen; Melody M Haag; Daria Guseva; Molly Hurd; Alisha A Linton; Brigitte Lavoie; Colleen B Kerrigan; Emily Joyce; Stephan C Bischoff; Steve Swann; Luana Griffin; Jun Matsukawa; Matthew D Falk; Tony S Gibson; Grant W Hennig; Jill Wykosky; Gary M Mawe
Journal:  Neurogastroenterol Motil       Date:  2020-11-12       Impact factor: 3.598

5.  Distribution of 5-HT3, 5-HT4, and 5-HT7 Receptors Along the Human Colon.

Authors:  Nor S Yaakob; Kenneth A Chinkwo; Navinisha Chetty; Ian M Coupar; Helen R Irving
Journal:  J Neurogastroenterol Motil       Date:  2015-07-30       Impact factor: 4.924

6.  Effect of the 5-HT4 receptor agonist tegaserod on the expression of GRK2 and GRK6 in the rat gastrointestinal tract.

Authors:  Teshome Nedi; Paul J White; Ian M Coupar; Helen R Irving
Journal:  BMC Res Notes       Date:  2018-06-08

Review 7.  Role of Microbiota and Tryptophan Metabolites in the Remote Effect of Intestinal Inflammation on Brain and Depression.

Authors:  Barbora Waclawiková; Sahar El Aidy
Journal:  Pharmaceuticals (Basel)       Date:  2018-06-25

8.  Altered Intestinal Permeability and Drug Repositioning in a Post-operative Ileus Guinea Pig Model.

Authors:  Young Min Kim; Zahid Hussain; Young Ju Lee; Hyojin Park
Journal:  J Neurogastroenterol Motil       Date:  2021-10-30       Impact factor: 4.924

9.  Potential role of fecal microbiota in patients with constipation.

Authors:  Yan Tian; Luo Zuo; Qin Guo; Jun Li; Zhangyong Hu; Kui Zhao; Can Li; Xiaohui Li; Jinggang Zhou; Yan Zhou; Xiao-An Li
Journal:  Therap Adv Gastroenterol       Date:  2020-10-31       Impact factor: 4.409

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.